NASDAQ:VOR

Vor Biopharma Stock Insider Trading

Healthcare > Biotechnology

Buy VOR

*Your capital is at risk

$21.15

-0.650 (-2.98%)

At Close: Jul 31, 2026

Vor Biopharma Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -79.61. In total, the insiders bought 13.13M and sold 12.07M VOR shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-79.61
● Buy	13.13M shares
● Sell	12.07M shares
23% Buy Activity Moderate Negative Correlation
Sell Signal High Confidence Apr 13, 2026 Analysis Breakdown: Strongly supported by a very low Insider Power Score of -79.61. Partially supported by a negative historical correlation. Confidence increased due to high data reliability score of 100. Supported by overwhelming sell-side pressure (23% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
Oct 21, 2025 Sell	Common Stock S-Sale	Ra Capital Management, L.p.	Director	25 027 Value: $703.5K
Oct 21, 2025 Sell	Common Stock S-Sale	Reprogrammed Interchange Llc 10 Percent Owner	10% Owner	200 Value: $6K
Oct 20, 2025 Sell	Common Stock S-Sale	Ra Capital Management, L.p.	Director	1 287 Value: $38.8K
Oct 20, 2025 Sell	Common Stock S-Sale	Ra Capital Management, L.p.	Director	13 817 Value: $409.4K
Oct 20, 2025 Sell	Common Stock S-Sale	Ra Capital Management, L.p.	Director	70 366 Value: $2.08M
Oct 20, 2025 Sell	Common Stock S-Sale	Ra Capital Management, L.p.	Director	6 553 Value: $197.4K
Oct 20, 2025 Sell	Common Stock S-Sale	Reprogrammed Interchange Llc 10 Percent Owner	10% Owner	11 616 Value: $349.1K
Oct 17, 2025 Sell	Common Stock S-Sale	Reprogrammed Interchange Llc 10 Percent Owner	10% Owner	24 689 Value: $746.1K
Oct 17, 2025 Sell	Common Stock S-Sale	Reprogrammed Interchange Llc 10 Percent Owner	10% Owner	1 028 Value: $31.9K
Oct 17, 2025 Sell	Common Stock S-Sale	Ra Capital Management, L.p.	Director	6 040 Value: $182.9K
Oct 17, 2025 Sell	Common Stock S-Sale	Ra Capital Management, L.p.	Director	34 284 Value: $998.4K
Oct 17, 2025 Sell	Common Stock S-Sale	Ra Capital Management, L.p.	Director	30 758 Value: $931.4K
Oct 17, 2025 Sell	Common Stock S-Sale	Ra Capital Management, L.p.	Director	174 594 Value: $5.08M
Oct 17, 2025 Sell	Common Stock S-Sale	Ra Capital Management, L.p.	Director	12 691 Value: $393.4K
Oct 17, 2025 Sell	Common Stock S-Sale	Ra Capital Management, L.p.	Director	2 492 Value: $77.3K
Oct 16, 2025 Sell	Common Stock S-Sale	Ra Capital Management, L.p.	Director	4 Value: $125
Oct 16, 2025 Sell	Common Stock S-Sale	Ra Capital Management, L.p.	Director	3 108 Value: $94.4K
Oct 16, 2025 Sell	Common Stock S-Sale	Ra Capital Management, L.p.	Director	111 041 Value: $3.26M
Oct 16, 2025 Sell	Common Stock S-Sale	Reprogrammed Interchange Llc 10 Percent Owner	10% Owner	2 021 Value: $61.5K
Oct 16, 2025 Sell	Common Stock S-Sale	Ra Capital Management, L.p.	Director	15 826 Value: $480.5K
Oct 16, 2025 Sell	Common Stock S-Sale	Ra Capital Management, L.p.	Director	20 Value: $627
Oct 16, 2025 Sell	Common Stock S-Sale	Ra Capital Management, L.p.	Director	21 804 Value: $639.3K
Oct 15, 2025 Sell	Common Stock S-Sale	Ra Capital Management, L.p.	Director	234 Value: $7K
Oct 15, 2025 Sell	Common Stock S-Sale	Reprogrammed Interchange Llc 10 Percent Owner	10% Owner	14 851 Value: $461.1K
Oct 15, 2025 Sell	Common Stock S-Sale	Reprogrammed Interchange Llc 10 Percent Owner	10% Owner	48 910 Value: $1.57M

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT VOR BIOPHARMA INC.

Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AML blood cancer cells. The company's eHSCs targeted therapies, such as CAR-Ts, bispecific antibodies, an...

Read Full Profile Here